Denmark vs Kiribati: The number of people with susceptibility test result for rifampicin
Denmark
96.58
in 2021
Kiribati
96.72
in 2021
Denmark rank
43rd
Kiribati rank
41st
The number of people with susceptibility test result for rifampicin over time
- Denmark
- Kiribati
How they compare
Kiribati currently reports 96.72 against 96.58 in Denmark, a difference of 0.14.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Denmark ahead.
Denmark ranks 43rd and Kiribati ranks 41st of 146 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Kiribati | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.19 | 66.85 | 30.34 | Denmark |
| 2020s | 96.41 | 93.91 | 2.5 | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Denmark or Kiribati?
- Kiribati, at 96.72 against 96.58 in Denmark as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Denmark and Kiribati?
- 0.14, with Kiribati ahead.
- How many years of comparable data are there for Denmark and Kiribati?
- 5 years are reported by both, from 2017 to 2021.
- How do Denmark and Kiribati rank globally for the number of people with susceptibility test result for rifampicin?
- Denmark ranks 43rd and Kiribati ranks 41st of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.